GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Research & Development

Voluntis (XPAR:ALVTX) Research & Development : €0.00 Mil (TTM As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Voluntis's Research & Development for the six months ended in Jun. 2021 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2021 was €0.00 Mil.

Voluntis Research & Development Historical Data

The historical data trend for Voluntis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Research & Development Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Research & Development
- - - - -

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Voluntis Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voluntis  (XPAR:ALVTX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Voluntis Research & Development Related Terms

Thank you for viewing the detailed overview of Voluntis's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Voluntis (XPAR:ALVTX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Research & Development
Comparable Companies
XPAR:MLLAB XPAR:SDT XPAR:ALINS VEEV TSE:2413 CERN HKSE:01833 TDOC TXG SZSE:300253 SDGR ONEM HQY XTER:COP CHNG INOV OMCL HMSY PINC SZSE:300451
Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Website
http://www.voluntis.com
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines